Sanara Medtech earnings were -$11.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SMTI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$3.5M, up 129.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SMTI reported annual earnings of -$9.7M, with 124.6% growth.
On SMTI's earnings call on Invalid Date, Sanara Medtech (NASDAQ: SMTI) reported Q1 2025 earnings per share (EPS) of -$0.41, up 95.24% year over year. Total SMTI earnings for the quarter were -$3.53 million. In the same quarter last year, Sanara Medtech's earnings per share (EPS) was -$0.21.
As of the last Sanara Medtech earnings report, Sanara Medtech is currently losing money. Sanara Medtech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$11.43 million, a 133.72% increase year over year.
What was SMTI's earnings growth in the past year?
As of Sanara Medtech's earnings date in Invalid Date, Sanara Medtech's earnings has grown year over year. SMTI earnings in the past year totalled -$11.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.